Caffeine and the Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus: Findings from Clinical and Experimental Studies.

caffeine intake coffee consumption diabetic retinopathy retinal ganglion cell layer tea consumption type 2 diabetes

Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
25 Feb 2023
Historique:
received: 31 12 2022
revised: 20 02 2023
accepted: 22 02 2023
entrez: 11 3 2023
pubmed: 12 3 2023
medline: 15 3 2023
Statut: epublish

Résumé

The aim of this study was to assess the potential benefits of caffeine intake in protecting against the development of diabetic retinopathy (DR) in subjects with type 2 diabetes (T2D). Furthermore, we tested the effect of topical administration of caffeine on the early stages of DR in an experimental model of DR. In the cross-sectional study, a total of 144 subjects with DR and 147 individuals without DR were assessed. DR was assessed by an experienced ophthalmologist. A validated food frequency questionnaire (FFQ) was administered. In the experimental model, a total of 20 mice were included. One drop (5 μL) of caffeine (5 mg/mL) (

Identifiants

pubmed: 36904168
pii: nu15051169
doi: 10.3390/nu15051169
pmc: PMC10005220
pii:
doi:

Substances chimiques

Caffeine 3G6A5W338E
Tea 0
Coffee 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Instituto de Salud Carlos III
ID : PS09/01035
Organisme : Instituto de Salud Carlos III
ID : FI11/0008
Organisme : Ministerio de Educación Cultura y Deporte
ID : FPU15/03005
Organisme : Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas
ID : CB15/00071
Organisme : Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas
ID : CB07/08/0024
Organisme : Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública
ID : CB06/02/0013

Références

Nutrients. 2022 Nov 25;14(23):
pubmed: 36501054
J Agric Food Chem. 2014 Jan 8;62(1):182-91
pubmed: 24295042
JAMA. 2005 Jul 6;294(1):97-104
pubmed: 15998896
Clin Exp Ophthalmol. 2016 May;44(4):260-77
pubmed: 26716602
Ophthalmic Res. 2016;55(4):212-8
pubmed: 26959995
PLoS One. 2014 May 16;9(5):e97302
pubmed: 24837086
J Cell Biochem. 2017 Aug;118(8):2371-2379
pubmed: 28106278
J Diabetes Res. 2015;2015:231570
pubmed: 26539551
Microcirculation. 2016 Oct;23(7):591-596
pubmed: 27653024
Health Qual Life Outcomes. 2014 Aug 20;12:131
pubmed: 25138117
Br J Ophthalmol. 2015 Dec;99(12):1628-33
pubmed: 26089211
Ophthalmology. 2003 Sep;110(9):1677-82
pubmed: 13129861
Jpn J Ophthalmol. 2002 Mar-Apr;46(2):170-6
pubmed: 12062222
Am J Public Health. 1999 Jun;89(6):862-7
pubmed: 10358676
J Immunol Res. 2020 May 28;2020:9680508
pubmed: 32566690
Nutr J. 2013 Feb 19;12:26
pubmed: 23421854
Acta Ophthalmol. 2012 Nov;90(7):e524-8
pubmed: 22863322
Antioxidants (Basel). 2019 Jun 10;8(6):
pubmed: 31185622
Invest Ophthalmol Vis Sci. 2013 Feb 15;54(2):1325-36
pubmed: 23299475
Clin Ophthalmol. 2008 Dec;2(4):801-16
pubmed: 19668434
J Korean Med Sci. 2013 Apr;28(4):608-13
pubmed: 23579598
Eur J Prev Cardiol. 2022 Dec 7;29(17):2240-2249
pubmed: 36162818
Diabetes. 2016 Jan;65(1):172-87
pubmed: 26384381
Nutrients. 2021 Mar 31;13(4):
pubmed: 33807132
Diabetes Care. 2022 Jan 1;45(Suppl 1):S185-S194
pubmed: 34964887
Cell Mol Neurobiol. 2022 Aug;42(6):1693-1725
pubmed: 33730305
Diabetes Metab Syndr. 2017 Dec;11 Suppl 2:S631-S635
pubmed: 28935543
Am J Clin Nutr. 2013 Mar;97(3):505-16
pubmed: 23364002
J Nutr. 2004 Oct;134(10):2528-33
pubmed: 15465742
Am J Clin Nutr. 1997 Apr;65(4 Suppl):1220S-1228S; discussion 1229S-1231S
pubmed: 9094926
Sci Rep. 2022 Mar 3;12(1):3547
pubmed: 35241707

Auteurs

Nuria Alcubierre (N)

Avantmedic Center, 25008 Lleida, Spain.

Minerva Granado-Casas (M)

Department of Nursing and Physiotherapy, Health Sciences Faculty, University of Lleida, 25198 Lleida, Spain.
Institute of Biomedical Research in Lleida (IRBLleida), 25198 Lleida, Spain.
Center for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, 08907 Barcelona, Spain.
DAP-Cat Group, Unitat de Suport a la Recerca Barcelona, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), 08041 Barcelona, Spain.

Patricia Bogdanov (P)

Center for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, 08907 Barcelona, Spain.
Diabetes and Metabolism Research Unit, Vall d'Hebron Research Institute (VHIR) and Autonomous University of Barcelona (UAB), 08035 Barcelona, Spain.

Cristina Hernández (C)

Center for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, 08907 Barcelona, Spain.
Diabetes and Metabolism Research Unit, Vall d'Hebron Research Institute (VHIR) and Autonomous University of Barcelona (UAB), 08035 Barcelona, Spain.

Hugo Ramos (H)

Center for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, 08907 Barcelona, Spain.
Diabetes and Metabolism Research Unit, Vall d'Hebron Research Institute (VHIR) and Autonomous University of Barcelona (UAB), 08035 Barcelona, Spain.

Esmeralda Castelblanco (E)

DAP-Cat Group, Unitat de Suport a la Recerca Barcelona, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), 08041 Barcelona, Spain.
Endocrinology, Metabolism and Lipid Research Division, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.

Jordi Real (J)

Center for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, 08907 Barcelona, Spain.
DAP-Cat Group, Unitat de Suport a la Recerca Barcelona, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), 08041 Barcelona, Spain.

Esther Rubinat-Arnaldo (E)

Department of Nursing and Physiotherapy, Health Sciences Faculty, University of Lleida, 25198 Lleida, Spain.
Institute of Biomedical Research in Lleida (IRBLleida), 25198 Lleida, Spain.
Center for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, 08907 Barcelona, Spain.

Alicia Traveset (A)

Institute of Biomedical Research in Lleida (IRBLleida), 25198 Lleida, Spain.
Department of Ophthalmology, University Hospital Arnau de Vilanova, 25198 Lleida, Spain.

Marta Hernández (M)

Institute of Biomedical Research in Lleida (IRBLleida), 25198 Lleida, Spain.
Department of Endocrinology & Nutrition, University Hospital Arnau de Vilanova, 25198 Lleida, Spain.

Carmen Jurjo (C)

Institute of Biomedical Research in Lleida (IRBLleida), 25198 Lleida, Spain.
Department of Ophthalmology, University Hospital Arnau de Vilanova, 25198 Lleida, Spain.

Jesús Vioque (J)

Nutritional Epidemiology Unit, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Miguel Hernández University, 46020 Alicante, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.

Eva Maria Navarrete-Muñoz (EM)

Grupo de Investigación en Terapia Ocupacional (InTeO), Department of Surgery and Pathology, Miguel Hernández University, 03550 Alicante, Spain.
Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), 03010 Alicante, Spain.

Rafael Simó (R)

Center for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, 08907 Barcelona, Spain.
Diabetes and Metabolism Research Unit, Vall d'Hebron Research Institute (VHIR) and Autonomous University of Barcelona (UAB), 08035 Barcelona, Spain.

Didac Mauricio (D)

Center for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, 08907 Barcelona, Spain.
DAP-Cat Group, Unitat de Suport a la Recerca Barcelona, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), 08041 Barcelona, Spain.
Department of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau & Institut d'Investigació Biomèdica Sant Pau (IIB Sant Pau), 08041 Barcelona, Spain.
Faculty of Medicine, University of Vic (UVIC/UCC), 08500 Vic, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH